Use the buttons below to increase or decrease the text size.
Use the toggle below to switch the contrast.
Listen to the content of the page by clicking play on Read Speaker.
To discover more about accessibility view our Accessibility Options
To all health facilities / all health care practitioners in Dubai's private health sector:
Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated
Drug Control Section
Health Regulation Sector
Add a warning to pharmaceuticals containing the active substance Febuxostat.pdf:
Recall one batch for pharmaceutical product Riazole 125mg 5ml Oral Suspension.pdf:
Safety update of a pharmaceutical product Androcur ( cyproterone acetate ).pdf:
You have shared the circular with
Could not share the circular with
Please check if you have entered valid email address
Please be advised that Sheryan doesn't support the current browser. Please use one of the recommended browsers.